Ogawa T, Moriwake T, Morimoto K, Sato M, Otsuki S
No To Shinkei. 1984 Oct;36(10):951-5.
Anticonvulsant and prophylactic effects of DN-1417, a novel TRH analog, were reported previously in kindled cat preparations which had been established as an experimental model of epilepsy. This study was conducted to examine an effect of DN-1417 on postictal events including postictal seizure inhibition (PSI). A recycling paradigm consisted of 8 amygdaloid stimuli at 1 hour intervals was applied to evaluate the PSI. Six of bilateral amygdaloid kindled cats were used. In control session, the left amygdala had been stimulated at final electroconvulsive threshold at 1 hour intervals in all cats. In drug session, the cats were pretreated with DN-1417 (4 mg/kg, i.v.) and exposed to recycling paradigm 20 minutes after the administration. The interval of each session was at least 2 weeks EEG recordings and behavioral observations were carried out at the same time. Effects of TRH tartrate (4 mg/kg, i.v.) on PSI was also investigated in 2 cats at the same paradigm. PSI was significantly prolonged and postictal EEG silence was significantly shortened by DN-1417. The pretreatment of TRH tartrate showed an prolongation of PSI in 2 cats respectively. These results suggest that administrated TRH analog or TRH may inhibit an occurrence of subsequent seizures and prevent the epileptic status.
一种新型促甲状腺激素释放激素类似物DN - 1417的抗惊厥和预防作用先前已在作为癫痫实验模型建立的点燃猫制剂中得到报道。本研究旨在检验DN - 1417对发作后事件(包括发作后癫痫发作抑制,PSI)的影响。采用每隔1小时进行8次杏仁核刺激的循环范式来评估PSI。使用了6只双侧杏仁核点燃的猫。在对照实验中,所有猫的左侧杏仁核均以最终电惊厥阈值每隔1小时进行刺激。在药物实验中,猫预先接受DN - 1417(4毫克/千克,静脉注射),并在给药后20分钟接受循环范式刺激。每个实验阶段的间隔至少为2周,同时进行脑电图记录和行为观察。还在相同范式下对2只猫研究了酒石酸促甲状腺激素释放激素(4毫克/千克,静脉注射)对PSI的影响。DN - 1417显著延长了PSI,显著缩短了发作后脑电图静息期。酒石酸促甲状腺激素释放激素预处理分别使2只猫的PSI延长。这些结果表明,给予促甲状腺激素释放激素类似物或促甲状腺激素释放激素可能抑制后续癫痫发作的发生并预防癫痫持续状态。